TAM
TENX icon

Tucker Asset Management’s Tenax Therapeutics TENX Stock Holding History

Tucker Asset Management’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1
Closed -$4 – 1788
2024
Q1 		$4 Buy
+1
New +$8 ﹤0.01% 1637
2023
Q4 		– Hold
0
– – – 1460
2023
Q3 		– Hold
0
– – – 1374
2023
Q2 		– Hold
0
– – – 1161
2023
Q1 		– Hold
0
– – – 1180
2022
Q4 		– Hold
0
– – – 837

Other funds holding TENX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Tucker Asset Management's TENX Position: Q2 2024 in Review

Tucker Asset Management sold out of Tenax Therapeutics (TENX) in Q2 2024, closing a stake of 1 share — an estimated $4 sold.

Tucker Asset Management first reported a position in TENX in Q1 2024 and held it in 1 quarter. The position peaked at $4 in Q1 2024. 11 funds tracked by Wall St. Rank hold TENX as of Q2 2024.

  • Tucker Asset Management reported no remaining Tenax Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Tucker Asset Management sold 1 Tenax Therapeutics share in Q2 2024, an estimated $4.
  • Tucker Asset Management first reported a position in Tenax Therapeutics in Q1 2024 and held it in 1 quarter.
  • Tucker Asset Management's Tenax Therapeutics position peaked at $4 in Q1 2024.
  • 11 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q2 2024.

Based on Tucker Asset Management's 13F filing for Q2 2024, filed 9 Aug 2024.